Finance ❯ Investments ❯ Securities

Public Companies

Investor Relations Investor Compensation Inovio Pharmaceuticals Eos Energy Enterprises, Inc. BlackRock TCP Capital Corp. ImmunityBio, Inc. NASDAQ Hercules Capital Nektar Therapeutics Ramaco Resources, Inc.

Robbins LLP Reminds Medpace Investors of June 8 Lead‑Plaintiff Deadline

The notice signals a push to select a lead investor to test claims about Medpace’s growth guidance.

Law Firms Urge Vital Farms Investors to Seek Lead Role in ERP-Related Securities Suits

ImmunityBio Investors Face May 26 Deadline to Seek Lead Role in Securities Case

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

Oddity Tech Hit With Securities Suits After Ad-Algorithm Disruption and 49% Stock Plunge

Law Firms Seek Lead Plaintiff in Lufax Securities Fraud Case

Investor Lawyers Press April Deadlines in Lakeland and Navan Securities Cases

Ramaco Resources Investors Get March 31 Cut-Off To Seek Lead Role In Securities Case

Eos Energy Hit With Securities Class Actions After Revenue Miss Triggers 39% Stock Drop

BlackRock TCP Investors Face April 6 Deadline in Securities Class Action

Ramaco Investors Urged To Seek Lead Plaintiff Status Before March 31 Deadline

Eos Energy Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Lakeland Industries Investors Face April 24 Deadline to Seek Lead Role in Securities Class Action

Law Firms Mobilize Investors in Eos Energy Securities Suit as May 5 Deadline Nears

Law Firms Urge Nektar Investors to Seek Lead Role in Securities Suit Over REZOLVE-AA Trial

Skye Bioscience Investors Face Jan. 16 Lead-Plaintiff Deadline in Lawsuit Over Nimacimab Claims

Rosen Sets Oct. 28 Deadline in Semler Scientific Securities Class Action

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action

Rosen Law Firm and KSF Remind Flywire Investors of September Lead-Plaintiff Deadline